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A Ab bs st tr ra ac ct t
Massively parallel short-tag sequencing of cDNA libraries - RNAseq - is being used to study the
dynamics and complexity of eukaryotic transcriptomes, giving new biological insights into the
‘active genome’.
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With the advent of third-generation sequencing technologies -
the so-called massively parallel sequencing technologies - it
is now possible to generate tens of millions of short
sequences (each typically 25-50 nucleotides long) in a single
assay. This technology has enabled the recent ‘RNA sequen-
cing’ (RNAseq), via random cDNA libraries, of the trans-
criptomes of yeasts, Arabidopsis, mouse embryonic stem
(ES) cells and other mouse tissues, and human cell lines.
These experiments are helping to redefine the understanding
of transcriptome content, complexity, and dynamics in these
species. A recent study by Bähler and colleagues [1] in the
fission yeast Schizosaccharomyces pombe in particular
shows how the new RNAseq technology is ideally suited to
revealing the changes that occur in transcriptional activity at
different stages in the yeast life cycle and in response to
changes in external conditions.
Conceptually, the RNAseq approach is very simple. Sequence
reads are generated from random locations along each RNA
by either sequencing sheared double-stranded cDNA
libraries [1-4] (strandless RNAseq), or by sequencing direc-
tional cDNA libraries prepared using either adaptor-tagged
random hexamers [5], or serial ligation of adaptors [6] to
fragmented RNA populations (stranded RNAseq). After
sequencing en masse, the short reads are then mapped back
against the appropriate reference genome or catalogues of all
exon-junction sequences to provide a global survey of
transcriptome activity (Figure 1).
A Ad dv va an nt ta ag ge es s   o of f   R RN NA As se eq q   f fo or r   i in nv ve es st ti ig ga at ti in ng g   t th he e
t tr ra an ns sc cr ri ip pt to om me e
RNAseq has several advantages over microarrays, the
traditional workhorse for transcriptomics. First, gene-
expression profiling by RNAseq has been shown to be very
robust and highly quantitative. The reproducibility of the
approach has been shown to be extremely high (Pearson
correlations of 0.99 have been reported for replicate RNAseq
runs) and raw tag counts correlate well with quantitative
real-time PCR results. For a microarray experiment, where
image-derived intensities are used to determine relative
abundance of transcripts, the dynamic range of expression is
constrained to a maximum of four to five orders of
magnitude. Although rare transcripts can be detected by
prolonging image exposure, the image becomes saturated for
the most highly expressed transcripts, and the relative
expression of these transcripts is lost. In contrast, the
dynamic range of RNAseq is potentially unlimited, as tag
counts are used to directly determine transcript abundance.
RNAseq is also potentially far more sensitive than micro-
array platforms. When sequence depths of 10-100 million
reads per biological sample are compared with expression
arrays, many genes whose activities are below detection limit
on the array are readily observed. Importantly, this
sensitivity is tuneable by altering sequencing depth. In the
case of S. pombe, for example, Wilhelm et al. [1] showed that
less than 1 Gb of mappable sequence was required forcomplete mRNA coverage, and other work has shown that
no more than 3-4 Gb is needed to obtain near complete
coverage of mammalian transcriptomes [3,5].
Expression profiling by RNAseq is also far more precise than
hybridization-based approaches, where RNAs sharing more
than 75% sequence identity to the probe will cross-hybridize
[7]. The high levels of sequence identity used for mapping
(96-100%) allow one to profile highly homologous trans-
cripts that would otherwise be confounded by cross-hybridi-
zation in microarray-based experiments. Repetitive sequences
have always been excluded from array probe designs for this
very reason, and these elements can now be profiled using
RNAseq.
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The identification of differential exon splicing by RNAseq. In this hypothetical genome-browser view, RNAseq tags (shown in red) are aligned to the
genome sequence, giving a quantitative view of tag densities across the locus. Genome-aligned reads identify individual exons and exon-exon junction
usage can be monitored by matching tags to a reference set of junction sequences. Differential exon-exon junction usage can be used to identify canonical
and alternative splicing events.
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tag densityUnlike arrays that use a defined set of probes to interrogate
RNA samples, RNAseq requires no previous assumptions
about which parts of the genome are transcriptionally active.
This provides the opportunity for transcriptome discovery,
and large amounts of novel expression have been reported in
budding and fission yeast [1,2], Arabidopsis [6], mouse ES
cells [5], mouse tissues [3] and human cell lines [4]. As much
as 25% of all observed expression in RNA sequence experi-
ments falls outside known exons for mammalian genomes [3-5].
B Bi io ol lo og gi ic ca al l   i in ns si ig gh ht ts s   f fr ro om m   R RN NA As se eq q
The large-scale survey of gene-expression space by traditional
sequencing of expressed sequence tags (ESTs) [8,9], and the
transcriptome annotation efforts of both the FANTOM
[10-12] and ENCODE [13] consortia have shown that
mammalian genomes are capable of generating 6-10 trans-
cripts per locus. Until now, one of the major challenges in
transcriptomics has been how to survey which of these
known RNAs are present in a single biological state. In
addition to monitoring gene activity, RNAseq can study
alternative splicing events, and the usage of promoters and
3’ untranslated regions (3’ UTRs). These events can be
detected by counting tags that match the portions of
sequence unique to each transcript. These so-called ‘diag-
nostic’ sequences may correspond to cassette exons or the
junction sequences arising from specific exon combinations.
The use of RNAseq has, for the first time, enabled
researchers to rapidly place genome-wide surveys of both
known and novel transcriptional complexity into a biological
context. For example, a recent RNAseq survey of human
embryonic kidney (HEK) 239T and Ramos B cells has shown
exon skipping to be the most common form of alternative
splicing in these cell lines [4]. However, by examining
different tissues, treatments or time-points, patterns of trans-
criptional complexity can be placed into biological context. A
common observation is the alternative use of extended UTRs
[1-3]. In S. pombe, Wilhelm et al. [1] demonstrated that the
lengths of 5’ and 3’ UTRs could be alternatively regulated
under different environmental conditions. During a sexual
differentiation time course, more than 20 genes were identi-
fied with dynamic 5’ UTR lengths, predominantly transition-
ing from short to long UTRs as cells exit mitosis. Many of the
genes identified have known functions in the cell cycle, or
were associated with the cell wall/cell surface; however the
mechanism governing UTR usage is not yet clear. The
parallel finding that mRNAs known to be unstable had
longer UTRs suggests that the extended UTRs may contain
regulatory signals that affect the stability of the mRNA. If
correct, this would enable tighter regulation of protein levels
during specific biological processes, implying flexibility in
regulatory networks.
In addition, Wilhelm et al. [1] showed that pre-mRNA
splicing in fission yeast is dynamically and biologically
regulated on a genome-wide scale. By surveying both rapidly
proliferating mitotic cells and induced meiotic reproduction
using a combination of strandless RNAseq with high-density
tiling arrays, they showed that as the expression of trans-
cripts increased, the efficiency with which those transcripts
were spliced (and therefore the overall proportion of spliced
to unspliced transcripts) also increased. These results point
to a functional link between transcriptional and splicing
machinery in S. pombe. A physical interaction between
transcription and pre-mRNA splicing has already been
established in mammalian cells (reviewed in [14,15]), and
the findings of Wilhelm et al. in yeast could highlight a
potential evolutionarily conserved mechanism to ensure the
efficiency of pre-mRNA processing [16].
In addition to identifying the presence and relative
abundance of known transcripts, RNAseq has regularly
identified novel transcriptional content and complexity. This
includes more than 200,000 retrotransposable elements
identified as transcriptionally active in mouse ES cells, of
which as many as 30,000 of these elements are dynamically
expressed during mouse ES cell differentiation [5]. RNAseq
is also not just a means for measuring the relative
abundance of transcripts, it is a massive-scale survey of
sequence content, enabling the simultaneous analysis of
gene expression and screening for sequence variation. While
this has not yet been pursued to any extent so far, the ability
of RNAseq to identify novel single nucleotide poly-
morphisms (SNPs) in exons has been shown [5].
C Ch ha al ll le en ng ge es s   f fo or r   R RN NA As se eq q   t te ec ch hn no ol lo og gy y
As with any new technology, there are currently various
limitations to RNAseq that will need to be addressed. First
and foremost is that it is based on resequencing. This means
that RNAseq is more useful for organisms that already have
good-quality reference genome sequences. Furthermore, the
ability to monitor transcriptional complexity as reported in
the recent papers is built on the foundation of previous
large-scale transcriptome annotation. In species where
genome builds are not complete, or where there is limited
EST and mRNA characterization, inferring the scale and
scope of transcriptional complexity will be challenging.
Mapping of the RNA sequence tags to the genome sequence
provides much needed precision in distinguishing the
expression of homologous genomic sequences, but it is still
not possible to discern the origin of a sequence tag that maps
to more than one location. This means that parts of the
transcriptome are undecipherable (known as multi-mapping
or ambiguous regions). Given that tags are typically between
20 and 40 nucleotides, approximately 10-20% of tags can
multi-map, especially when mapping strategies normally
allow for a number of mismatches between the tag and the
reference sequence to account for SNPs or systematic error.
While tags of limited ambiguity (those that map to less than
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origin using computational approaches, such events are
undesirable. This is especially true when examining novel
events associated with expression from those regions, such
as novel splice variants or SNPs. Highly ambiguous exonic
sequences will remain ‘black holes’ in the genome until
advances in sequencing technology increase the read length
to the point where the tag extends into sufficient unique
sequence to allow unambiguous mapping. In addition, the
effect of genomic variation (such as copy-number variations,
structural variations or ploidy) on accurate and unbiased tag
mapping has yet to be systematically studied. Nevertheless,
it is anticipated that improvements and advances in these
technologies will see tag lengths increase and systematic
error decrease, both of which will dramatically shrink the
current black holes in reference genomes.
There is also opportunity for improvement in almost every
part of the RNA workflow. In the case of library
preparation, most experiments have used double-stranded
cDNA libraries that are sheared and then sequenced en
masse. The problem with this approach is that the
directionality of the fragment is lost, so that precise
mapping of its origin to a specific strand in the genome is
also lost. In higher eukaryotes, where overlapping sense
and antisense transcripts are abundant, this is far from
desirable. It is also unclear how PCR or ligation steps in
other library preparation methods may bias the tag content
of the libraries.
Current RNAseq methods are not yet suitable for samples
where only small amounts of RNA are available. The various
reported protocols use from as little as 20 mg to as much as 1
mg of total RNA. While it is conceivable that RNA ampli-
fication steps could be used to generate enough starting
material, those libraries would be significantly less complex
and, therefore, their sensitivity would be compromised.
Despite these caveats, RNAseq is heralding a new period in
transcriptomics and is bringing much needed sensitivity and
discrimination to global gene expression assays. The power
of the new sequencing technologies means it is now feasible
to sequence the complete transcriptome in short random
fragments, thus providing the opportunity to measure the
expression of all known transcripts as well as systematically
screening for novel expression. As with microarray profiling,
it is anticipated that as the number of biological states
surveyed by RNAseq increases in each species, it will be
possible to put much of this new-found complexity into
biological context. Being able to accurately survey sequence
variation and gene activity simultaneously should enable a
single experiment to yield large amounts of diverse informa-
tion: for example, screening for mutations, monitoring
allele-specific expression and studying post-transcriptional
events, such as RNA editing, simultaneously in a single
pathological sample.
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